174 related articles for article (PubMed ID: 31090214)
21. DNA methyltransferase and demethylase in human prostate cancer.
Patra SK; Patra A; Zhao H; Dahiya R
Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulators of programmed death-ligand 1 expression in human cancers.
Kumar S; Sharawat SK
Transl Res; 2018 Dec; 202():129-145. PubMed ID: 30401465
[TBL] [Abstract][Full Text] [Related]
23. Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance.
Martin AM; Nirschl TR; Nirschl CJ; Francica BJ; Kochel CM; van Bokhoven A; Meeker AK; Lucia MS; Anders RA; DeMarzo AM; Drake CG
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):325-32. PubMed ID: 26260996
[TBL] [Abstract][Full Text] [Related]
24. Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.
Kishikawa S; Murata T; Kimura H; Shiota K; Yokoyama KK
Eur J Biochem; 2002 Jun; 269(12):2961-70. PubMed ID: 12071960
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation mechanism of intracellular zinc deficiency-induced injury in primary hippocampal neurons in the rat brain.
He CC; Wang ZY; Tian K; Liu W; Li YB; Hong Y; Yu LX; Pang W; Jiang YG; Liu YQ
Nutr Neurosci; 2018 Sep; 21(7):478-486. PubMed ID: 28421879
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238
[TBL] [Abstract][Full Text] [Related]
28. Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1.
Frauer C; Rottach A; Meilinger D; Bultmann S; Fellinger K; Hasenöder S; Wang M; Qin W; Söding J; Spada F; Leonhardt H
PLoS One; 2011 Feb; 6(2):e16627. PubMed ID: 21311766
[TBL] [Abstract][Full Text] [Related]
29. Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis.
Grenga I; Donahue RN; Gargulak ML; Lepone LM; Roselli M; Bilusic M; Schlom J
Urol Oncol; 2018 Mar; 36(3):93.e1-93.e11. PubMed ID: 29103968
[TBL] [Abstract][Full Text] [Related]
30. Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation.
von Hardenberg J; Hartmann S; Nitschke K; Worst TS; Ting S; Reis H; Nuhn P; Weis CA; Erben P
Clin Genitourin Cancer; 2019 Apr; 17(2):145-153.e5. PubMed ID: 30709785
[TBL] [Abstract][Full Text] [Related]
31. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
32. DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.
Kim H; Park J; Jung Y; Song SH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
Int J Oncol; 2010 Jun; 36(6):1563-72. PubMed ID: 20428781
[TBL] [Abstract][Full Text] [Related]
33. DNA Methyltransferase 1 Is Dysregulated in Parkinson's Disease via Mediation of miR-17.
Zhang HQ; Wang JY; Li ZF; Cui L; Huang SS; Zhu LB; Sun Y; Yang R; Fan HH; Zhang X; Zhu JH
Mol Neurobiol; 2021 Jun; 58(6):2620-2633. PubMed ID: 33483902
[TBL] [Abstract][Full Text] [Related]
34. Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide.
Calagua C; Russo J; Sun Y; Schaefer R; Lis R; Zhang Z; Mahoney K; Bubley GJ; Loda M; Taplin ME; Balk SP; Ye H
Clin Cancer Res; 2017 Nov; 23(22):6812-6822. PubMed ID: 28893901
[No Abstract] [Full Text] [Related]
35. Epigenetic abnormalities of classical Hodgkin lymphoma and its effect on immune escape.
Liu Y; Huang R; Liu L; Meng Y; Liu X
Cell Biochem Funct; 2020 Apr; 38(3):242-248. PubMed ID: 31709594
[TBL] [Abstract][Full Text] [Related]
36. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H
Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778
[TBL] [Abstract][Full Text] [Related]
37. The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain
Ng C; Aichinger M; Nguyen T; Au C; Najar T; Wu L; Mesa KR; Liao W; Quivy JP; Hubert B; Almouzni G; Zuber J; Littman DR
Genes Dev; 2019 Jun; 33(11-12):669-683. PubMed ID: 30975723
[TBL] [Abstract][Full Text] [Related]
38. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G
J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.
Wang HC; Chen CW; Yang CL; Tsai IM; Hou YC; Chen CJ; Shan YS
Cancer Immunol Res; 2017 Oct; 5(10):885-897. PubMed ID: 28835422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
